UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of left ventricular mass change during treatment of hypertension

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (19), p.2350

2004

Volltextzugriff (PDF)

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (19), p.2343

2004

Volltextzugriff (PDF)

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation : The losartan intervention for end point reduction in hypertension (LIFE) study

Journal of the American College of Cardiology, 2005-03, Vol.45 (5), p.705-711

2005

Volltextzugriff (PDF)

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

The Lancet (British edition), 2002-03, Vol.359 (9311), p.1004-1010

2002

Volltextzugriff (PDF)

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Annals of internal medicine, 2003-12, Vol.139 (11), p.901

2003

Volltextzugriff (PDF)

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

JAMA : the journal of the American Medical Association, 2002-09, Vol.288 (12), p.1491

2002

Volltextzugriff (PDF)

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2002-09, Vol.20 (9), p.1879-1886

2002

Volltextzugriff (PDF)

Tackling ACE-inhibitor cough

The Lancet (British edition), 1997-12, Vol.350 (9094), p.1854-1855

Aurup, Peter

1997

Volltextzugriff (PDF)

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

Circulation (New York, N.Y.), 2003-08, Vol.108 (6), p.684-690

2003

Volltextzugriff (PDF)

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy

Journal of hypertension, 2002-09, Vol.20 (9), p.1855-1864

2002

Volltextzugriff (PDF)

Losartan and renal transplantation

The Lancet (British edition), 1998-03, Vol.351 (9107), p.990-990

1998

Volltextzugriff (PDF)

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

Annals of internal medicine, 2003-08, Vol.139 (3), p.169

2003

Volltextzugriff (PDF)

A033: Impact of antihypertensive treatment on left ventricular geometric patterns: The preserve study

American journal of hypertension, 2000-04, Vol.13 (S2), p.52A-52A

2000

Volltextzugriff (PDF)

Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension

The American journal of cardiology, 2001-03, Vol.87 (6), p.721-726

2001

Volltextzugriff (PDF)

Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction

BMJ, 1993-09, Vol.307 (6904), p.585-587

International edition, 1993

Volltextzugriff (PDF)

Y Lacourcière, L Poirier, J Lefebvre. A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure. Can J Cardiol 2000;16:1155-1166

Canadian journal of cardiology, 2001-03, Vol.17 (3), p.345-346

2001

Volltextzugriff (PDF)

Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study

European journal of clinical investigation, 1995-01, Vol.25 (1), p.15-18

1995

Volltextzugriff (PDF)

Losartan and renal transplantation [letter]

The Lancet (British edition), 1998-03, Vol.351 (9107), p.990

1998

Volltextzugriff (PDF)

The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET Study

International journal of cardiology, 1993-06, Vol.39 (3), p.187-193

1993

Volltextzugriff (PDF)

THE SAFETY AND EFFICACY OF LOSARTAN/HYDROCHLOROTHIAZIDE IN THE TREATMENT OF PATIENTS WITH SEVERE HYPERTENSION; A MULTICENTER STUDY: P2.39

Journal of hypertension, 2000-06, Vol.18, p.S99

2000

Volltextzugriff (PDF)

E059 Long term blood pressure control with losartan alone or in combination with hydrochlorothiazide or other antihypertensive drugs in patients with mild to moderate essential hypertension

American journal of hypertension, 1998-04, Vol.11 (S3), p.110A-110A

1998

Volltextzugriff (PDF)

Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies

Clinical cardiology (Mahwah, N.J.), 1997-08, Vol.20 (8), p.704-710

Mosller, M

1997

Volltextzugriff (PDF)

Myocardial contractility and performance capacity after magnesium infusions in young healthy persons: A double‐blind, placebo‐controlled, cross‐over study

Clinical cardiology (Mahwah, N.J.), 1988-08, Vol.11 (8), p.541-545

1988

Volltextzugriff (PDF)

B016 Long term safety of losartan in open label trials in patients with mild to moderate essential hypertension

American journal of hypertension, 1998-04, Vol.11 (S3), p.43A-43A

1998

Volltextzugriff (PDF)

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

The Lancet (British edition), 2002-03, Vol.23, p.1004-1010

2002

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(41)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Middle Aged
(18)
Aged
(17)
Female
(17)
Male
(17)
General & Internal Medicine
(13)
Medicine, General & Internal
(13)
Pharmacology. Drug Treatments
(13)
Antihypertensive Agents - Therapeutic Use
(12)
Losartan - Therapeutic Use
(12)
Double-Blind Method
(11)
Hypertension - Drug Therapy
(11)
Medicin Och Hälsovetenskap
(10)
Atenolol - Therapeutic Use
(9)
Cardiovascular System
(9)
Hypertension
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic significance of left ventricular mass change during treatment of hypertension

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation : The losartan intervention for end point reduction in hypertension (LIFE) study

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Tackling ACE-inhibitor cough

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy

Losartan and renal transplantation

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

A033: Impact of antihypertensive treatment on left ventricular geometric patterns: The preserve study

Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension

Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction

Y Lacourcière, L Poirier, J Lefebvre. A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure. Can J Cardiol 2000;16:1155-1166

Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study

Losartan and renal transplantation [letter]

The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET Study

THE SAFETY AND EFFICACY OF LOSARTAN/HYDROCHLOROTHIAZIDE IN THE TREATMENT OF PATIENTS WITH SEVERE HYPERTENSION; A MULTICENTER STUDY: P2.39

E059 Long term blood pressure control with losartan alone or in combination with hydrochlorothiazide or other antihypertensive drugs in patients with mild to moderate essential hypertension

Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies

Myocardial contractility and performance capacity after magnesium infusions in young healthy persons: A double‐blind, placebo‐controlled, cross‐over study

B016 Long term safety of losartan in open label trials in patients with mild to moderate essential hypertension

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Suchergebnisse filtern